-+ 0.00%
-+ 0.00%
-+ 0.00%

*Kalaris Therapeutics: Potential Initiation of a Phase 3 Program Now Expected in 2028, Resulting in Extension of Anticipated Cash Runway Into 2028 and Beyond Preliminary Phase 1b/2 Data Readout >KLRS

Dow Jones·11/10/2026 12:33:20